Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Current Deferred Revenue: 2009-2024

Historic Current Deferred Revenue for Gyre Therapeutics (GYRE) over the last 14 years, with Dec 2024 value amounting to $61,000.

  • Gyre Therapeutics' Current Deferred Revenue rose 61.11% to $58,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $58,000, marking a year-over-year increase of 61.11%. This contributed to the annual value of $61,000 for FY2024, which is 56.41% up from last year.
  • Gyre Therapeutics' Current Deferred Revenue amounted to $61,000 in FY2024, which was up 56.41% from $39,000 recorded in FY2023.
  • Gyre Therapeutics' 5-year Current Deferred Revenue high stood at $2.0 million for FY2020, and its period low was $39,000 during FY2023.
  • Moreover, its 3-year median value for Current Deferred Revenue was $61,000 (2024), whereas its average is $81,667.
  • Per our database at Business Quant, Gyre Therapeutics' Current Deferred Revenue tumbled by 88.40% in 2021 and then soared by 56.41% in 2024.
  • Over the past 5 years, Gyre Therapeutics' Current Deferred Revenue (Yearly) stood at $2.0 million in 2020, then slumped by 88.40% to $230,000 in 2021, then plummeted by 36.96% to $145,000 in 2022, then tumbled by 73.10% to $39,000 in 2023, then soared by 56.41% to $61,000 in 2024.